Other products from "FERRING PHARMACEUTICALS INC."
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 07640180261018 10mg Demonstration Kit 55566-1903-1 Needle-free delivery device for use with ZOMACTON (somatropin) for Injection 10m Needle-free delivery device for use with ZOMACTON (somatropin) for Injection 10mg vial, 7 Head A's, Carry Case and User Manual. KZE Injector, Fluid, Non-Electrically Powered 2 ZOMA-Jet
2 07640180261001 5mg Demonstration Kit 55566-1803-1 Needle-fre4e delivery device for use with ZOMACTON (somatropin) for Injection 5m Needle-fre4e delivery device for use with ZOMACTON (somatropin) for Injection 5mg vial, 5 Head A's, Carry Case and User Manual. KZE Injector, Fluid, Non-Electrically Powered 2 ZOMA-Jet
Other products with the same Product Code "MOZ"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 25060432190006 HYLAN GF-20 injectable (hyaluronic acid, intra-articular) SYNVISC FCL HEALTH SOLUTIONS LTD
2 20358468019114 002401 Acid, Hyaluronic, Intraarticular Synvisc-One® GENZYME CORPORATION
3 15060432190009 HYLAN GF-20 Acid, Hyaluronic, Intraarticular SYNVISC ONE FCL HEALTH SOLUTIONS LTD
4 M717715655550 89130-5555-01 7156-5555 SUPARTZ (P980044) is indicated for treatment of pain in osteoarthritis (OA) of t SUPARTZ (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from rooster combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution). SUPARTZ® sodium hyaluronate SEIKAGAKU CORPORATION
5 M717715644440 89130-4444-1 7156-4444 SUPARTZ FX (P980044) is indicated for treatment of pain in osteoarthritis (OA) o SUPARTZ FX (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ FX is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from chicken combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ FX is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution). SUPARTZ FX sodium hyaluronate SEIKAGAKU CORPORATION
6 M71389122496630SAM1 FID185704 FID185704 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FIDIA FARMACEUTICI SPA
7 M71389122496630A16 89122-4966-30 89122-4966-30 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FIDIA FARMACEUTICI SPA
8 M71389122087901SAM1 M71389122087901SAM1A FID10000317 TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL - Profes TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL - Professional Sample - Not for Sale TriLURON FIDIA FARMACEUTICI SPA
9 M71389122087901A1 M71389122087901A13 89122-0879-01 TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL TriLURON FIDIA FARMACEUTICI SPA
10 M71389122072420A1 89122-0724-20 89122-0724-20 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the t Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days. Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL FIDIA FARMACEUTICI SPA
11 M71389122072412A1 89122-0724-12 89122-0724-12 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the trea Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days. Hyalgan® Sodium Hyaluronate 2mL Vial FIDIA FARMACEUTICI SPA
12 M71389122049663SAM1 FID185704 FID185704 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FIDIA FARMACEUTICI SPA
13 M71389122049663A16 89122-0496-63 89122-0496-63 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FIDIA FARMACEUTICI SPA
14 M713891220496010 89122-0496-01 89122-0496-01 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking. The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. The product is packaged in a one syringe pack. Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack FIDIA FARMACEUTICI SPA
15 10886705025183 690-016 4 mL, 22 mg/mL High Molecular Weight Hyaluronan Monovisc ANIKA THERAPEUTICS, INC.
16 10886705023110 630-254 2 mL, 15 mg/mL High Molecular weight Hyaluronan Orthovisc ANIKA THERAPEUTICS, INC.
17 08033638951057 GS3111 INTRA-ARTICULAR HYALURONIC ACID. 1 PRE-FILLED SYRINGE CONTAINING 16.8 mg / 2 mL INTRA-ARTICULAR HYALURONIC ACID. 1 PRE-FILLED SYRINGE CONTAINING 16.8 mg / 2 mL HYALURONIC ACID SODIUM SALT GELSYN-3 IBSA FARMACEUTICI ITALIA SRL
18 07640128544210 4100 1% sodium hyaluronate Euflexxa FERRING PHARMACEUTICALS INC.
19 05060604130065 N/A Monovisc ACRE PHARMA LIMITED
20 05060604130041 N/A Synvisc ACRE PHARMA LIMITED
21 05060604130034 NA Inject into the knee to relieve the pain from osteoarthritis. Synvisc One ACRE PHARMA LIMITED
22 05060604130027 NA Injected into the knee to relieve the pain from osteoarthritis. Supartz ACRE PHARMA LIMITED
23 05060604130010 NA Inject into the knee to relieve the pain caused by osteoarthritis. Orthovisc ACRE PHARMA LIMITED
24 05060604130003 NA Injected into the knee to relieve the pain from osteoarthritis. Euflexxa ACRE PHARMA LIMITED
25 05060548950071 N/A Durolane PAVAN TRADING LTD
26 05060548950064 None Euflexxa is injected into the knee to relieve the pain of osteoarthritis. Euflexxa PAVAN TRADING LTD
27 05060548950057 None Supartz is injected into the knee to relieve the pain of osteoarthritis. Supartz PAVAN TRADING LTD
28 05060548950033 None Monovisc is injected into the knee to relieve the pain of osteoarthritis. Monovisc PAVAN TRADING LTD
29 05060548950026 None Orthovisc is injected into the knee joint to cushion and lubricate. Orthovisc PAVAN TRADING LTD
30 05060548950019 None Synvisc is injected into the knee to alleviate the pain of osteoarthritis. Synvisc One (Synvisc Three) PAVAN TRADING LTD
31 05060519180056 NA Euflexxa PROPHARMA-UK LTD
32 05060519180032 NA Synvisc One PROPHARMA-UK LTD
33 05060519180025 NA Supartz PROPHARMA-UK LTD
34 05060519180018 NA Orthovisc PROPHARMA-UK LTD
35 05060519180001 NA Hyalgan PROPHARMA-UK LTD
36 05060497630048 5 Count Synvisc PHARMACEUTICAL HEALTH LIMITED
37 05060497630031 NA Supartz PHARMACEUTICAL HEALTH LIMITED
38 05060497630024 NA Orthovisc PHARMACEUTICAL HEALTH LIMITED
39 05060497630017 NA Euflexxa PHARMACEUTICAL HEALTH LIMITED
40 05060497630000 NA Synvisc PHARMACEUTICAL HEALTH LIMITED
41 05060459970120 NA Supartz ALLY MEDICAL SUPPLIES LTD
42 05060459970090 None Monovisc ALLY MEDICAL SUPPLIES LTD
43 05060459970052 None Hyalgan ALLY MEDICAL SUPPLIES LTD
44 05060459970045 None Euflexxa ALLY MEDICAL SUPPLIES LTD
45 05060459970038 None Orthovisc ALLY MEDICAL SUPPLIES LTD
46 05060459970021 None Synvisc One ALLY MEDICAL SUPPLIES LTD
47 05060459970007 None Synvisc ALLY MEDICAL SUPPLIES LTD
48 05060432190026 NA Monovisc FCL HEALTH SOLUTIONS LTD
49 05060432190019 NA Supartz FCL HEALTH SOLUTIONS LTD
50 04987541301314 00-1111-001-03 00-1111-001-03 VISCO-3 (P980044/S027) is indicated for treatment of pain in osteoarthritis (OA) VISCO-3 (P980044/S027) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.VISCO-3 is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from chicken combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. VISCO-3 is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution). VISCO-3 sodium hyaluronate SEIKAGAKU CORPORATION